Inhibition of lymph node metastasis by an anti-angiogenic agent, TNP-470
1997

Inhibition of Lymph Node Metastasis by TNP-470

Sample size: 20 publication Evidence: moderate

Author Information

Author(s): Y Ohta, Y Watanabe, T Tabata, M Oda, Y Hayashi, Y Endo, M Tanaka, T Sasaki

Primary Institution: Kanazawa University

Hypothesis

Does TNP-470 inhibit lymph node metastasis in a metastatic model system using athymic nude mice?

Conclusion

TNP-470 effectively inhibits lymph node metastasis in a dose-dependent manner.

Supporting Evidence

  • All mice in the no treatment group showed lymph node metastasis.
  • The inhibition ratios of lymph node metastasis were 82.3% at 10 mg kg-1, 97.2% at 30 mg kg-1, and 97.5% at 100 mg kg-1.
  • The treatment with TNP-470 at 100 mg kg-1 reduced the size of the primary lesion.

Takeaway

This study found that a drug called TNP-470 can help stop cancer from spreading to lymph nodes in mice.

Methodology

Athymic nude mice were injected with HT-1080 cells and treated with varying doses of TNP-470; lymph nodes were analyzed for metastasis.

Limitations

The study was conducted on mice, and results may not directly translate to humans.

Participant Demographics

Five-week-old female athymic Balb/c nude mice.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication